News

Filter

Current filters:

ADC Therapeutics

Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive

Jay Feingold appointed CMO at ADC Therapeutics amid large-scale hiring drive

30-09-2014

Oncology drug development company focused on antibody drug conjugates targeting major cancers, ADC Therapeutics,…

ADC TherapeuticsBoardroomOncologyPharmaceuticalSwitzerland

Executive Q&A: ADC Therapeutics’ chief executive Michael Forer

Executive Q&A: ADC Therapeutics’ chief executive Michael Forer

19-03-2014

In an interview with The Pharma Letter, CEO Michael Forer discusses ADC Therapeutics' developing pipeline…

ADC TherapeuticsBiotechnologyInterviewsNorthern EuropeOncology

ADC Therapeutics signs license agreement with Five Prime

ADC Therapeutics signs license agreement with Five Prime

05-11-2013

Swiss ADC Therapeutics, a portfolio company of Auven Therapeutics, and Five Prime Therapeutics (NASDAQ:…

ADC TherapeuticsBiotechnologyEuropeLicensingNorth AmericaOncology

AstraZeneca boosts oncology portfolio with up to $440 million acquisition

AstraZeneca boosts oncology portfolio with up to $440 million acquisition

15-10-2013

AstraZeneca revealed this morning that its biologics subsidiary MedImmune has acquired Spirogen, a privately-held…

ADC TherapeuticsAstraZenecaMedImmuneMergers & AcquisitionsOncologyPharmaceuticalSpirogen

ADC Therapeutics and BZL Biologics sign antibody agreement

15-07-2013

Swiss ADC Therapeutics, a portfolio company of Auven Therapeutics, and USA-based BZL Biologics today…

ADC TherapeuticsAuven TherapeuticsBiotechnologyBZL BiologicsEuropeLicensingOncology

Genmab and ADC Thera link for antibody drug conjugate combining HuMax-TAC and PBD warhead

18-06-2013

Denmark's Genmab (OMX: GEN) and Switzerland-based ADC Therapeutics have entered an agreement to develop…

ADC TherapeuticsBiotechnologyGenmabHuMax-TACLicensingOncologyResearch

Celtic Therapeutics sets up $50 million Swiss ADC company

26-03-2012

USA-based private equity firm Celtic Therapeutics Management has announced a significant commitment to…

ADC TherapeuticsBiotechnologyCancer Research TechnologyCeltic TherapeuticsFinancialOncologyPharmaceuticalResearchSpirogen

Back to top